Nitrogen, Except As Cyano, Attached Indirectly To A Ring By Acyclic Nonionic Bonding (e.g., Benzyl Rosanilines, Etc.) Patents (Class 552/111)
  • Patent number: 10723745
    Abstract: Provided is an improved process for the preparation N-[4-[[4-(diethyl amino) phenyl](2,5-disulfophenyl)methylene]-2,5-cyclohexadien-1-ylidene]-N-ethylethanaminium inner salt sodium salt (Isosulfan blue) of formula I. It also relates to highly pure novel crystalline form of Isosulfan blue hydrate and its process for the preparation thereof. It also relates to an improved process for the preparation of Isosulfan blue sodium hydrate having not more than 0.2% of desethyl impurity of formula A.
    Type: Grant
    Filed: September 6, 2016
    Date of Patent: July 28, 2020
    Assignee: BIOPHORE INDIA PHARMACEUTICALS PVT. LTD.
    Inventors: Manik Reddy Pullagurla, Mecheril Valsan Nanda Kumar, Bhaskar Reddy Pitta, Suresh Babu Namana, Jagadeesh Babu Rangisetty, Sadashiv Choppari
  • Patent number: 7097669
    Abstract: Colorant compositions are useful for a wide variety of product applications. For example, colorants are used in tinting of polymers, providing colors to aqueous solution(s), and affording color to solid or semi-solid products such as detergents. Disclosed herein are colorant compositions having a triphenylmethane (“TPM”) derived structure having improved stability to alkaline conditions. Thus, the colorant compositions resist decolorization, even at relatively high pH levels. The colorant compositions of the invention are useful as applied in polyolefins, such as polypropylene and polyethylene, as examples. These colorant compositions also may be employed in thermoplastics, such as PET, for example.
    Type: Grant
    Filed: November 18, 2004
    Date of Patent: August 29, 2006
    Assignee: Milliken & Company
    Inventors: Eric B. Stephens, Pat Moore
  • Patent number: 6533826
    Abstract: Process for preparing aqueous solutions of cationic di- and triarylmethane dyes by the aqueous dye solution, which contains organic solvents, being concentrated by nanofiltration and optionally diluted with water.
    Type: Grant
    Filed: February 8, 2001
    Date of Patent: March 18, 2003
    Assignee: BASF Aktiengesellschaft
    Inventors: Thomas Gessner, Gunter-Rudolf Schröder, Robert Reinhardt
  • Publication number: 20020198370
    Abstract: A labeling reagent for use in oligonucleotide (“oligo”) synthesis, as well as a method of preparing such a labeling reagent, a method of using such a reagent for synthesizing a labeled oligonucleotide, and an oligonucleotide prepared using such a reagent. The reagent can be used to label either the 3′ or 5′ termini of a synthesized oligo, and/or for one or more positions along the oligo. The labeling reagent can be prepared by a reaction scheme that involves the initial preparation of hydroxyacids, tritylated hydroxyacids and coupling of such derivatives to diamine, wherein the amine function serves at an attachment point for labels and the hydroxyl groups can either be used to immoblize the molecules to support or can be converted to provide a phosphorylating reagent.
    Type: Application
    Filed: June 4, 2001
    Publication date: December 26, 2002
    Inventor: Tomas Kempe
  • Patent number: 5922890
    Abstract: New trityl linkers for use in solid phase synthesis comprise compounds of formula II ##STR1## wherein R.sub.4 is alkyl (e.g. C.sub.1-4 alkyl), halogen, NO.sub.2, or hydrogen;Z is a coupling group chosen from acylamido, acyloxy, amino, halogen, thiol or hydroxyl,where acyl is the residue of a carboxylic acid or a residue of formula R.sub.5 CO where R.sub.5 is an organic group;Y is H, a reactive functional group or an attachment to a solid phase;W is O when Y is H or a reactive functional group, or W is --NH--, or --NR.sub.6 --(urethane) when Y is an attachment to a solid phase,where R.sub.6 is an organic group and,each R which, may be the same or different, is C(O)NR.sub.7 R.sub.8, CF.sub.3, F or Cl wherein each R.sub.7 and R.sub.8, which may be the same or different, is H or C.sub.
    Type: Grant
    Filed: December 3, 1997
    Date of Patent: July 13, 1999
    Assignee: Novartis AG
    Inventor: Konrad Bleicher